Faeth Therapeutics (FTH) Amortizatization of Intangibles (2020 - 2026)
Faeth Therapeutics' (FTH) quarterly Amortizatization of Intangibles came in at $1000.0 in Q1 2026, down 75.0% YoY from $4000.0 in Q1 2025, and down 75.0% on a QoQ basis from $4000.0 in Q4 2025.
Faeth Therapeutics (FTH) Amortizatization of Intangibles (2020 - 2026) Analysis & Trends
Faeth Therapeutics (FTH) has 6 years of Amortizatization of Intangibles data on file, last reported at $1000.0 in Q1 2026.
- Quarterly Amortizatization of Intangibles fell 75.0% year-over-year to $1000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $14000.0 (down 97.59% YoY) and the FY2025 annual result came in at $17000.0, down 97.8% from the prior year.
- Amortizatization of Intangibles slipped to $1000.0 in Q1 2026, from $4000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $197000.0 in Q1 2023 to a low of $1000.0 in Q1 2026.
- A 5-year average of $135411.8 and a median of $191000.0 in 2022 frame the typical range for Amortizatization of Intangibles.
- Annual changes were most pronounced in 2023 — Amortizatization of Intangibles gained 11.3% — and 2025, when it sank 97.94%.
- Tracing FTH's Amortizatization of Intangibles over 5 years: stood at $189000.0 in 2022, then gained by 2.65% to $194000.0 in 2023, then fell by 1.03% to $192000.0 in 2024, then plunged by 97.92% to $4000.0 in 2025, then slumped by 75.0% to $1000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $1000.0 (Q1 2026), $4000.0 (Q4 2025), and $4000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 678,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Faeth Therapeutics | 179.31 Mn | 179.31 Mn | - | 389,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,000.00 |
| Mar 31, 2026 | 1,000.00 |
| Dec 31, 2025 | 4,000.00 |
| Dec 31, 2025 | 4,000.00 |
| Sep 30, 2025 | 4,000.00 |
| Sep 30, 2025 | 4,000.00 |
| Jun 30, 2025 | 5,000.00 |
| Jun 30, 2025 | 5,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Dec 31, 2024 | 192,000.00 |
| Dec 31, 2024 | 192,000.00 |
| Sep 30, 2024 | 192,000.00 |
| Sep 30, 2024 | 192,000.00 |
| Jun 30, 2024 | 193,000.00 |
| Jun 30, 2024 | 193,000.00 |
| Mar 31, 2024 | 194,000.00 |
| Mar 31, 2024 | 194,000.00 |
| Dec 31, 2023 | 194,000.00 |
| Dec 31, 2023 | 194,000.00 |